A fair growth of 6.31% in the revenue at Rs. 6292.30 millions was reported in the March 2026 quarter as compared to Rs. 5919.10 millions during year-ago period.Net Profit of the company move down -39.62% to Rs. 1998.20 millions from Rs. 3309.40 millions in the same quarter last year.Operating profit surged to 2766.70 millions from the corresponding previous quarter of 2720.80 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	6292.30	5919.10	6.31	25196.50	22813.50	10.45	25196.50	22813.50	10.45
Other Income	407.20	445.80	-8.66	1879.50	1722.50	9.11	1879.50	1722.50	9.11
PBIDT	2766.70	2720.80	1.69	10920.40	9124.80	19.68	10920.40	9124.80	19.68
Interest	21.10	26.90	-21.56	94.80	84.10	12.72	94.80	84.10	12.72
PBDT	2836.00	4422.00	-35.87	10334.00	10768.80	-4.04	10334.00	10768.80	-4.04
Depreciation	147.80	164.00	-9.88	577.30	607.90	-5.03	577.30	607.90	-5.03
PBT	2688.20	4258.00	-36.87	9756.70	10160.90	-3.98	9756.70	10160.90	-3.98
TAX	690.00	948.60	-27.26	2532.40	2484.90	1.91	2532.40	2484.90	1.91
Deferred Tax	23.60	-42.00	-156.19	-42.80	-156.10	-72.58	-42.80	-156.10	-72.58
PAT	1998.20	3309.40	-39.62	7224.30	7676.00	-5.88	7224.30	7676.00	-5.88
Equity	457.50	457.50	0.00	457.50	457.50	0.00	457.50	457.50	0.00
PBIDTM(%)	43.97	45.97	-4.34	43.34	40.00	8.36	43.34	40.00	8.36

Pfizer Ltd.